Celularity Net Income From Continuing Ops from 2010 to 2024

CELUW Stock  USD 0.02  0  23.50%   
Celularity Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss is likely to outpace its year average in 2024. During the period from 2010 to 2024, Celularity Net Loss regression line of quarterly data had mean square error of 2860.5 T and geometric mean of  7,834,861. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-196.3 M
Current Value
-186.5 M
Quarterly Volatility
70.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.6 M, Interest Expense of 2.5 M or Selling General Administrative of 48.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Latest Celularity's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Celularity over the last few years. It is Celularity's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Celularity Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(32,855,456)
Geometric Mean7,834,861
Coefficient Of Variation(214.95)
Mean Deviation53,430,897
Median2,512,971
Standard Deviation70,624,333
Sample Variance4987.8T
Range210.5M
R-Value(0.68)
Mean Square Error2860.5T
R-Squared0.47
Significance0
Slope(10,797,318)
Total Sum of Squares69829.1T

Celularity Net Income From Continuing Ops History

2024-186.5 M
2023-196.3 M
202214.2 M
2021-100.1 M
2020-49.3 M

About Celularity Financial Statements

Celularity investors use historical fundamental indicators, such as Celularity's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Celularity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-196.3 M-186.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.